Related Experiment Video
Updated: Jun 19, 2026
10:09
Transtubular Endoscopic Posterolateral Decompression for L5-S1 Lumbar Lateral Disc Herniation
Published on: October 14, 2022
Clinical diagnosis for discogenic low back pain
Yin-gang Zhang1, Tuan-mao Guo, Xiong Guo
1Department of Orthopaedics, First Affiliated Hospital, Medical College of Xi'an Jiaotong University, Xi'an 710061, PR China. zyingang@mail.xjtu.edu.cn
International Journal of Biological Sciences
|October 23, 2009
Summary
Discogenic lower back pain (DLBP) is the most common cause of chronic low back pain (LBP). Future serum biomarkers may offer easier, more accurate diagnoses for DLBP.
Area of Science:
- Orthopedics
- Pain Medicine
- Biochemistry
Background:
- Discogenic lower back pain (DLBP) is the most prevalent cause of chronic low back pain (LBP), affecting 39% of patients.
- A significant challenge in managing LBP is the difficulty in identifying specific pathological causes, with only about 20% of cases precisely diagnosed.
- Other causes of LBP, like disc herniation and zygapophysial joint pain, have lower prevalence rates than DLBP.
Purpose of the Study:
- To review the current clinical diagnostic process for DLBP.
- To explore the future potential of serum biomarkers for diagnosing DLBP.
- To highlight the benefits of serum biomarker use in improving diagnostic accuracy and reproducibility.
Main Methods:
- Literature review of clinical diagnostic methods for DLBP.
- Discussion of emerging research on serum biomarkers for LBP.
- Analysis of the potential impact of biomarker-based diagnostics on clinical practice.
Main Results:
- The clinical diagnosis of DLBP remains challenging due to the complexity of LBP.
- Serum biomarkers show promise for simplifying and improving the accuracy of DLBP diagnosis.
- Biomarker-based diagnosis could lead to more consistent and reliable results compared to current methods.
Conclusions:
- Accurate diagnosis of DLBP is critical for effective patient management.
- Serum biomarkers represent a promising advancement for the future diagnosis of DLBP.
- The integration of serum biomarkers could revolutionize the diagnostic approach to chronic low back pain.
Related Concept Videos
01:23Degenerative Disc Disease ll: Pathophysiology
The symptoms of degenerative disc disease arise from a combination of mechanical compression, vascular compromise, and biochemical inflammation, which together disrupt nerve function and produce pain.Mechanical CompressionDisc degeneration reduces height and elasticity, predisposing to herniation of the nucleus pulposus, a major cause of radicular pain. Herniations may be protrusion (bulging with intact annulus), extrusion (nucleus extends beyond disc but remains connected), or sequestration...
01:27Degenerative Disc Disease I: Introduction
Degenerative disc disease is a chronic condition in which intervertebral discs gradually lose structure and function. It is not infectious or autoimmune; rather, it results from age-related biochemical and mechanical changes, influenced by genetic, metabolic, and environmental factors.Structure and Function of DiscsThe spine contains 23 intervertebral discs that absorb load, distribute forces, maintain spacing, and allow flexibility. Each disc consists of a nucleus pulposus, a gel-like core...
01:29Herniated Intervertebral Disc l: Introduction
Intervertebral disc herniation refers to the displacement of the nucleus pulposus (the gel-like inner core of the disc) through a tear or weakened area in the annulus fibrosus (the outer fibrous ring). The displaced disc material extends beyond the normal boundaries of the disc space and may compress or irritate nearby spinal nerve roots or, less commonly, the spinal cord.Etiology and Risk FactorsHerniation commonly results from degeneration, in which aging reduces disc hydration and...